Article
Hyperoside Suppresses Osteoclasts Differentiation and Function through Down-Regulating TRAF6/p38 MAPK Signaling Pathway
2021-06-30
Abstract excerpt
<title>Abstract</title> <p>Background: Osteoporosis (OP) is a systemic metabolic bone disease that the bone resorption exceeds the bone formation,resulting in reduced bone mass, degeneration of the microstructure of bone tissue, and then increased bone fragility and fracture risk. Hyperoside (HP), as a natural product, can promote proliferation and differentiation of osteoblasts and presents a protective effect o...
Topics
Open a Topic to create a Post that cites this publication.
- Bone health and osteoporosis research
- Bone health and treatments
- Bone Metabolism and Diseases
- Cytokine Signaling Pathways and Interactions
- Inflammatory mediators and NSAID effects
- Oral microbiology and periodontitis research
- Pharmacological Effects of Medicinal Plants
- Wnt/β-catenin signaling in development and cancer
Identifiers and source
- Literature Corpus work
- d084f1ab-c68f-5448-bcc2-47f016d0c113
- DOI
- 10.21203/rs.3.rs-655369/v1
